Skip navigation

Chemical Pregnenes

1–50 of 662 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Pesticides [Pesticides results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
2. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Soil Pollutants [Soil Pollutants results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
3. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in increased progesterone receptor signaling pathway 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
4. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway alpha-hexachlorocyclohexane [alpha-hexachlorocyclohexane results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
5. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway beta-hexachlorocyclohexane [beta-hexachlorocyclohexane results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
6. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Lindane [Lindane results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
7. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway delta-hexachlorocyclohexane [delta-hexachlorocyclohexane results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
8. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Aldrin [Aldrin results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
9. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Dieldrin [Dieldrin results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
10. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Endrin [Endrin results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
11. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway o,p'-DDT [o,p'-DDT results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
12. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway DDT [DDT results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
13. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Dichlorodiphenyl Dichloroethylene [Dichlorodiphenyl Dichloroethylene results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
14. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Dichlorodiphenyldichloroethane [Dichlorodiphenyldichloroethane results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
15. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Chlordan [Chlordan results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
16. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Heptachlor [Heptachlor results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
17. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Toxaphene [Toxaphene results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
18. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway phenanthrene [phenanthrene results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
19. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway pyrene [pyrene results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
20. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway Benzo(a)pyrene [Benzo(a)pyrene results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
21. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway 2,2',3,3',4,4',5-heptachlorobiphenyl [2,2',3,3',4,4',5-heptachlorobiphenyl results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
22. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway PCB 180 [PCB 180 results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
23. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway 3,4,5,3',4'-pentachlorobiphenyl [3,4,5,3',4'-pentachlorobiphenyl results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
24. 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione progesterone receptor signaling pathway 2,3',4,4',5-pentachlorobiphenyl [2,3',4,4',5-pentachlorobiphenyl results in decreased progesterone receptor signaling pathway] which results in decreased susceptibility to 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione 1: Homo sapiens Osteoblasts | Cell Line, Tumor 1 gene: PGR 1
25. 17,20-dihydroxy-4-pregnen-3-one androgen receptor signaling pathway 17,20-dihydroxy-4-pregnen-3-one results in increased androgen receptor signaling pathway 1: Gnathopogon caerulescens Sertoli Cells   1
26. Aldosterone renal sodium excretion AVP | Propranolol [Propranolol co-treated with AVP protein co-treated with Aldosterone] results in increased renal sodium excretion 1: Rattus norvegicus Kidney   1
27. Aldosterone renal sodium excretion Aldosterone results in decreased renal sodium excretion 1: Homo sapiens Nephrons   1
28. Aldosterone renal sodium excretion NPPA NPPA inhibits the reaction [Aldosterone results in decreased renal sodium excretion] 1: Homo sapiens Nephrons   1
29. Aldosterone apoptotic process Aldosterone results in increased apoptotic process 1: Rattus norvegicus Podocytes | Cells, Cultured
14 genes: AQP2 | CASP3 | DAB2 | FASLG | GAS6 | HMOX1 | JAK2 | MAPK1 | MAPK14 | MAPK3 | NR3C1 | PRKCA | PRKD1 | SGK1
1
30. Aldosterone MAPK cascade Aldosterone results in increased MAPK cascade 1: Rattus norvegicus Podocytes | Cells, Cultured
6 genes: EGFR | IL18 | JAK2 | MAPK1 | MAPK3 | TGFB1
1
31. Aldosterone apoptotic process wortmannin wortmannin promotes the reaction [Aldosterone results in increased apoptotic process] 1: Rattus norvegicus Podocytes | Cells, Cultured
14 genes: AQP2 | CASP3 | DAB2 | FASLG | GAS6 | HMOX1 | JAK2 | MAPK1 | MAPK14 | MAPK3 | NR3C1 | PRKCA | PRKD1 | SGK1
1
32. Aldosterone apoptotic process Spironolactone Spironolactone inhibits the reaction [Aldosterone results in increased apoptotic process] 1: Rattus norvegicus Podocytes | Cells, Cultured
14 genes: AQP2 | CASP3 | DAB2 | FASLG | GAS6 | HMOX1 | JAK2 | MAPK1 | MAPK14 | MAPK3 | NR3C1 | PRKCA | PRKD1 | SGK1
1
33. Aldosterone MAPK cascade Spironolactone Spironolactone inhibits the reaction [Aldosterone results in increased MAPK cascade] 1: Rattus norvegicus Podocytes | Cells, Cultured
6 genes: EGFR | IL18 | JAK2 | MAPK1 | MAPK3 | TGFB1
1
34. Aldosterone regulation of blood pressure Clonidine [Clonidine results in decreased abundance of Aldosterone] which results in decreased regulation of blood pressure 1: Homo sapiens Cardiovascular System
18 genes: ACE | ACTA2 | AGT | AGTR1A | AGTR2 | ATP1A1 | CYP11B2 | EDN1 | EDNRA | HMOX1 | NPPA | NPPB | POMC | PPARG | REN | SCNN1A | SGK1 | SOD1
1
35. Aldosterone apoptotic process Aldosterone results in increased apoptotic process 1: Rattus norvegicus Myocytes, Cardiac | Cells, Cultured
14 genes: AQP2 | CASP3 | DAB2 | FASLG | GAS6 | HMOX1 | JAK2 | MAPK1 | MAPK14 | MAPK3 | NR3C1 | PRKCA | PRKD1 | SGK1
1
36. Aldosterone apoptotic process NOL3 NOL3 protein inhibits the reaction [Aldosterone results in increased apoptotic process] 1: Rattus norvegicus Myocytes, Cardiac | Cells, Cultured
14 genes: AQP2 | CASP3 | DAB2 | FASLG | GAS6 | HMOX1 | JAK2 | MAPK1 | MAPK14 | MAPK3 | NR3C1 | PRKCA | PRKD1 | SGK1
1
37. Aldosterone apoptotic process CASP8 CASP8 protein affects the reaction [Aldosterone results in increased apoptotic process] 1: Rattus norvegicus Myocytes, Cardiac | Cells, Cultured
14 genes: AQP2 | CASP3 | DAB2 | FASLG | GAS6 | HMOX1 | JAK2 | MAPK1 | MAPK14 | MAPK3 | NR3C1 | PRKCA | PRKD1 | SGK1
1
38. Aldosterone apoptotic process FASLG FASLG protein affects the reaction [Aldosterone results in increased apoptotic process] 1: Rattus norvegicus Myocytes, Cardiac | Cells, Cultured
14 genes: AQP2 | CASP3 | DAB2 | FASLG | GAS6 | HMOX1 | JAK2 | MAPK1 | MAPK14 | MAPK3 | NR3C1 | PRKCA | PRKD1 | SGK1
1
39. Aldosterone apoptotic process CASP8 | NOL3 NOL3 protein affects the reaction [CASP8 protein affects the reaction [Aldosterone results in increased apoptotic process]] 1: Rattus norvegicus Myocytes, Cardiac | Cells, Cultured
14 genes: AQP2 | CASP3 | DAB2 | FASLG | GAS6 | HMOX1 | JAK2 | MAPK1 | MAPK14 | MAPK3 | NR3C1 | PRKCA | PRKD1 | SGK1
1
40. Aldosterone ion transport Aldosterone results in increased ion transport 1: Rattus norvegicus Kidney Tubules, Collecting
10 genes: ATP1A1 | KCNJ5 | SCNN1A | SCNN1B | SCNN1G | SLC12A2 | SLC30A1 | SLC39A1 | SLC9A1 | SLC9A3
1
41. Aldosterone positive regulation of urine volume Aldosterone deficiency results in increased positive regulation of urine volume 1: Homo sapiens Urine
2 genes: EDN1 | NPPB
1
42. Aldosterone renal sodium excretion Aldosterone deficiency results in increased renal sodium excretion 1: Homo sapiens Urine   1
43. Aldosterone positive regulation of urine volume Heparin [Heparin results in decreased abundance of Aldosterone] which results in increased positive regulation of urine volume 1: Homo sapiens Urine
2 genes: EDN1 | NPPB
1
44. Aldosterone renal sodium excretion Heparin [Heparin results in decreased abundance of Aldosterone] which results in increased renal sodium excretion 1: Homo sapiens Urine   1
45. Aldosterone regulation of blood pressure Nifedipine [Nifedipine results in decreased regulation of blood pressure] which results in decreased abundance of Aldosterone 1: Homo sapiens Cardiovascular System
18 genes: ACE | ACTA2 | AGT | AGTR1A | AGTR2 | ATP1A1 | CYP11B2 | EDN1 | EDNRA | HMOX1 | NPPA | NPPB | POMC | PPARG | REN | SCNN1A | SGK1 | SOD1
1
46. Aldosterone regulation of blood pressure Angiotensin-Converting Enzyme Inhibitors [Angiotensin-Converting Enzyme Inhibitors results in decreased regulation of blood pressure] which results in decreased abundance of Aldosterone 1: Homo sapiens Cardiovascular System
18 genes: ACE | ACTA2 | AGT | AGTR1A | AGTR2 | ATP1A1 | CYP11B2 | EDN1 | EDNRA | HMOX1 | NPPA | NPPB | POMC | PPARG | REN | SCNN1A | SGK1 | SOD1
2
47. Aldosterone regulation of blood pressure Angiotensin-Converting Enzyme Inhibitors | Nifedipine [Nifedipine promotes the reaction [Angiotensin-Converting Enzyme Inhibitors results in decreased regulation of blood pressure]] which results in decreased abundance of Aldosterone 1: Homo sapiens Cardiovascular System
18 genes: ACE | ACTA2 | AGT | AGTR1A | AGTR2 | ATP1A1 | CYP11B2 | EDN1 | EDNRA | HMOX1 | NPPA | NPPB | POMC | PPARG | REN | SCNN1A | SGK1 | SOD1
1
48. Aldosterone regulation of blood pressure Angiotensin-Converting Enzyme Inhibitors | Nifedipine [Angiotensin-Converting Enzyme Inhibitors promotes the reaction [Nifedipine results in decreased regulation of blood pressure]] which results in decreased abundance of Aldosterone 1: Homo sapiens Cardiovascular System
18 genes: ACE | ACTA2 | AGT | AGTR1A | AGTR2 | ATP1A1 | CYP11B2 | EDN1 | EDNRA | HMOX1 | NPPA | NPPB | POMC | PPARG | REN | SCNN1A | SGK1 | SOD1
1
49. Aldosterone vasoconstriction Aldosterone results in increased vasoconstriction 1: Homo sapiens Blood Vessels
6 genes: ACE | AGT | AGTR1A | CAV1 | EDN1 | EDNRA
1
50. Aldosterone vasoconstriction Nitroprusside Aldosterone inhibits the reaction [Nitroprusside results in increased vasoconstriction] 1: Homo sapiens Blood Vessels
6 genes: ACE | AGT | AGTR1A | CAV1 | EDN1 | EDNRA
1
1–50 of 662 results.